Drug Shortage Report for PMS-FLUTICASONE HFA

Last updated on 2024-07-10 History
Report ID 208562
Drug Identification Number 02503115
Brand name PMS-FLUTICASONE HFA
Common or Proper name FLUTICASONE HFA
Company Name PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) FLUTICASONE PROPIONATE
Strength(s) 50MCG
Dosage form(s) METERED-DOSE AEROSOL
Route of administration ORAL INHALATION
Packaging size 120
ATC code R03BA
ATC description OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-10-27
Estimated end date 2025-06-01
Actual end date
Shortage status Actual shortage
Updated date 2024-07-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2023-10-30 English Compare
v2 2023-10-30 French Compare
v3 2023-10-30 English Compare
v4 2023-10-30 French Compare
v5 2024-02-16 English Compare
v6 2024-02-16 French Compare
v7 2024-04-12 English Compare
v8 2024-04-12 French Compare
v9 2024-07-10 English Compare
v10 2024-07-10 French Compare

Showing 1 to 10 of 10